Sign inGet started

AMGEN INC

Insider CIK 318154 · MITI 10% owner · TLOG 10% owner · EPZM 10% owner · KZR 10% owner · BGNE 10% owner · VIGL 10% owner · NMRA 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NMRA Neumora Therapeutics, Inc. C Conversion deriv2023-09-192023-09-1932,754,291— $00SEC↗
NMRA Neumora Therapeutics, Inc. C Conversion deriv2023-09-192023-09-19849,657— $00SEC↗
NMRA Neumora Therapeutics, Inc. P Buy2023-09-192023-09-191,764,705$17.00 $30.00M35,368,653SEC↗
NMRA Neumora Therapeutics, Inc. C Conversion2023-09-192023-09-1933,603,948— $033,603,948SEC↗
VIGL Vigil Neuroscience, Inc. C Conversion deriv2022-01-112022-01-113,206,281— $00SEC↗
VIGL Vigil Neuroscience, Inc. C Conversion2022-01-112022-01-113,206,281— $03,206,281SEC↗
BGNE BeiGene, Ltd. P Buy2021-09-102021-09-13165,529$302.06 $50.00M18,943,802SEC↗
BGNE BeiGene, Ltd. A Award2020-12-182020-12-1825,762$260.95 $6.72M18,778,273SEC↗
BGNE BeiGene, Ltd. A Award2020-12-172020-12-1774,624$260.54 $19.44M18,752,511SEC↗
BGNE BeiGene, Ltd. A Award2020-12-162020-12-1785,573$248.26 $21.24M18,677,887SEC↗
BGNE BeiGene, Ltd. A Award2020-12-152020-12-1767,941$239.31 $16.26M18,592,314SEC↗
BGNE BeiGene, Ltd. A Award2020-08-252020-08-2559,390$248.49 $14.76M18,524,373SEC↗
BGNE BeiGene, Ltd. A Award2020-08-242020-08-2459,390$239.10 $14.20M18,464,983SEC↗
BGNE BeiGene, Ltd. A Award2020-08-212020-08-2464,176$230.18 $14.77M18,405,593SEC↗
BGNE BeiGene, Ltd. A Award2020-08-202020-08-2064,176$234.99 $15.08M18,341,417SEC↗
BGNE BeiGene, Ltd. A Award2020-08-192020-08-2064,176$234.88 $15.07M18,277,241SEC↗
BGNE BeiGene, Ltd. A Award2020-08-182020-08-2040,000$230.18 $9.21M18,213,065SEC↗
BGNE BeiGene, Ltd. A Award2020-07-152020-07-1629,614,832$14.23 $421.42M236,249,845SEC↗
KZR Kezar Life Sciences, Inc. C Conversion deriv2018-06-252018-06-251,121,384— $00SEC↗
KZR Kezar Life Sciences, Inc. C Conversion2018-06-252018-06-251,121,384— $01,121,384SEC↗
TLOG TETRALOGIC PHARMACEUTICALS C Conversion deriv2013-12-172013-12-1813,355— $00SEC↗
TLOG TETRALOGIC PHARMACEUTICALS C Conversion deriv2013-12-172013-12-180— $00SEC↗
TLOG TETRALOGIC PHARMACEUTICALS C Conversion deriv2013-12-172013-12-18117,361— $00SEC↗
TLOG TETRALOGIC PHARMACEUTICALS X Exercise deriv2013-12-172013-12-180— $00SEC↗
TLOG TETRALOGIC PHARMACEUTICALS C Conversion deriv2013-12-172013-12-18108,932— $00SEC↗
TLOG TETRALOGIC PHARMACEUTICALS C Conversion2013-12-172013-12-18448,767— $0448,767SEC↗
TLOG TETRALOGIC PHARMACEUTICALS X Exercise2013-12-172013-12-181,141$6.40 $7.3K269,257SEC↗
TLOG TETRALOGIC PHARMACEUTICALS P Buy2013-12-172013-12-18272,142$7.00 $1.90M541,399SEC↗
TLOG TETRALOGIC PHARMACEUTICALS C Conversion2013-12-172013-12-18268,116— $0268,116SEC↗
EPZM Epizyme, Inc. C Conversion deriv2013-06-052013-06-05952,381— $00SEC↗
EPZM Epizyme, Inc. P Buy2013-06-052013-06-0516,666$15.00 $250.0K334,126SEC↗
EPZM Epizyme, Inc. C Conversion2013-06-052013-06-05317,460— $0317,460SEC↗
MITI MICROMET, INC. P Buy2012-03-072012-03-0715,951,220$11.00 $175.46M100,635,409SEC↗
MITI MICROMET, INC. P Buy2012-03-072012-03-0711,181,711$11.00 $123.00M0SEC↗
MITI MICROMET, INC. P Buy2012-03-062012-03-072,170,710$11.00 $23.88M84,684,189SEC↗
MITI MICROMET, INC. P Buy2012-03-052012-03-062,035,994$11.00 $22.40M82,513,479SEC↗
MITI MICROMET, INC. P Buy2012-03-022012-03-06452,388$11.00 $4.98M80,477,485SEC↗